Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells

Journal of Cell Science

Volumn 123, Issue 10, 2010, Pages 1634-1643

  Lee, Young H ^a   Mungunsukh, Ognoon ^a   Tutino, Rebecca L ^a   Marquez, Ana P ^a   Day, Regina M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Ang II; Bcl xL; Intrinsic apoptosis; mRNA half life; Nucleolin; SHP 2

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; MESSENGER RNA; NUCLEOLIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN TYROSINE PHOSPHATASE SHP 2; RNA; CASPASE; PHOSPHOPROTEIN; PROTEIN BCL X; PROTEIN BINDING; RNA BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CHANNEL GATING; COMET ASSAY; CONTROLLED STUDY; CYTOSOL; DNA FRAGMENTATION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE CONTROL; HALF LIFE TIME; IMMUNOPRECIPITATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY; PULMONARY ARTERY; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BOVINAE; CELL CULTURE; DRUG EFFECTS; GENETICS; LUNG FIBROSIS; METABOLISM; PATHOLOGY;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; BCL-X PROTEIN; CASPASES; CATTLE; CELLS, CULTURED; CYTOCHROMES C; ENDOTHELIAL CELLS; ENZYME ACTIVATION; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PULMONARY ARTERY; PULMONARY FIBROSIS; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 77952359125     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.063545     Document Type: Article

References (66)

1. Alvarez, S. E., Seguin, L. R., Villarreal, R. S., Nahmias, C. and Ciuffo, G. M. (2008). Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fetal tissues. J. Cell Biochem. 105, 703-711.
2. Bachelor, M. A. and Bowden, G. T. (2004). Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes: post-transcriptional regulation through the 3′-untranslated region. J. Biol. Chem. 279, 42658-42668.
3. Bader, M. (2002). Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J. Mol Cell. Cardiol. 34, 1455-1462.
4. Bataller, R., Sancho-Bru, P., Gines, P. and Brenner, D. A. (2005). Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid. Redox Signal. 7, 1346-1355.
5. Bedecs, K., Elbaz, N., Sutren, M., Masson, M., Susini, C., Strosberg, A. D. and Nahmias, C. (1997). Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem. J. 325, 449-454.
6. Bennett, A. M., Hausdorff, S. F., O'Reilly, A. M., Freeman, R. M. and Neel, B. G. (1996). Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell. Biol. 16, 1189-1202.
7. Berchtold, S., Volarevic, S., Moriggl, R., Mercep, M. and Groner, B. (1998). Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Mol. Endocrinol. 12, 556-567.
8. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G. and Thompson, C. B. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
9. Brechler, V., Reichlin, S., De Gasparo, M. and Bottari, S. P. (1994). Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Recept. Channels 2, 89-98. (Pubitemid 24262696)
10. Chong, Z. Z. and Maiese, K. (2007). The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol. Histopathol. 22, 1251-1267.
11. Cui, T., Nakagami, H., Iwai, M., Takeda, Y., Shiuchi, T., Daviet, L., Nahmias, C. and Horiuchi, M. (2001). Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc. Res. 49, 863-871. (Pubitemid 32178390)
12. D'Amore, A., Black, M. J. and Thomas, W. G. (2005). The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46, 1347-1354. (Pubitemid 43189734)
13. Dendorfer, A., Dominiak, P. and Schunkert, H. (2005). ACE inhibitors and angiotensin II receptor antagonists. Handb. Exp. Pharmacol. 170, 407-442
14. Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J. and Zeiher, A. M. (1997). Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res. 81, 970-976.
15. Farkas, L., Farkas, D., Ask, K., Moller, A., Gauldie, J., Margetts, P., Inman, M. and Kolb, M. (2009). VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J. Clin. Invest. 119, 1298-1311.
16. Feng, Y. H., Sun, Y. and Douglas, J. G. (2002). Gbeta gamma-independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1. Proc. Natl. Acad. Sci. USA 99, 12049-12054.
17. Friedman, S. L. (2004). Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1, 98-105.
18. Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T. and Dzau, V. J. (1997). Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272, 19022-19026. (Pubitemid 27318258)
19. Horiuchi, M., Akishita, M. and Dzau, V. J. (1998). Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr. Res. 24, 307-314.
20. Kito, S., Shimizu, K., Okamura, H., Yoshida, K., Morimoto, H., Fujita, M., Morimoto, Y., Ohba, T. and Haneji, T. (2003). Cleavage of nucleolin and argyrophilic nucleolar organizer region associated proteins in apoptosis-induced cells. Biochem. Biophys. Res. Commun. 300, 950-956.
21. Kitta, K., Day, R. M., Ikeda, T. and Suzuki, Y. J. (2001). Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic. Biol. Med. 31, 902-910. (Pubitemid 32925088)
22. Konigshoff, M., Wilhelm, A., Jahn, A., Sedding, D., Amarie, O. V., Eul, B., Seeger, W., Fink, L., Gunther, A., Eickelberg, O. et al. (2007). The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am. J. Respir. Cell Mol. Biol. 37, 640-650.
23. Kren, B. T., Trembley, J. H., Krajewski, S., Behrens, T. W., Reed, J. C. and Steer, C. J. (1996). Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration. Cell Growth Differ. 7, 1633-1642.
24. Krown, K. A., Page, M. T., Nguyen, C., Zechner, D., Gutierrez, V., Comstock, K. L., Glembotski, C. G., Quintana, P. J. E. and Sabbadini, R. A. (1996). Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98, 2854-2865.
25. Li, C. Y., Chu, J. Y., Yu, J. K., Huang, X. Q., Liu, X. J., Shi, L., Che, Y. C. and Xie, J. Y. (2004). Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Res. 14, 473-479.
26. Li, D., Yang, B., Philips, M. I. and Mehta, J. L. (1999). Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am. J. Physiol. 276, H786-H792. (Pubitemid 29157449)
27. Li, J. M., Mogi, M., Tsukuda, K., Tomochika, H., Iwanami, J., Min, L. J., Nahmias, C., Iwai, M. and Horiuchi, M. (2007). Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol. Endocrinol. 21, 499-511.
28. Marrero, M. B., Venema, V. J., Ju, H., Eaton, D. C. and Venema, R. C. (1998). Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am. J. Physiol. 275, C1216-C1223.
29. Marshall, R. P. (2003). The pulmonary renin-angiotensin system. Curr. Pharm. Des. 9, 715-722.
30. Matsubara, H., Shibasaki, Y., Okigaki, M., Mori, Y., Masaki, H., Kosaki, A., Tsutsumi, Y., Uchiyama, Y., Fujiyama, S., Nose, A. et al. (2001). Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor. Biochem. Biophys. Res. Commun. 282, 1085-1091.
31. McClenahan, D., Hellenbrand, K., Atapattu, D., Aulik, N., Carlton, D., Kapur, A. and Czuprynski, C. (2008). Effects of lipopolysaccharide and Mannheimia haemolytica leukotoxin on bovine lung microvascular endothelial cells and alveolar epithelial cells. Clin. Vaccine Immunol. 15, 338-347.
32. Mogi, M., Iwai, M. and Horiuchi, M. (2007). Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler. Thromb. Vasc. Biol. 27, 2532-2539.
33. Noguchi, T., Matozaki, T., Horita, K., Fujioka, Y. and Kasuga, M. (1994). Role of SHPTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell. Biol. 14, 6674-6682.
34. Nouet, S. and Nahmias, C. (2000). Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol. Metab. 11, 1-6.
35. Otake, Y., Soundararajan, S., Sengupta, T. K., Kio, E. A., Smith, J. C., Pineda-Roman, M., Stuart, R. K., Spicer, E. K. and Fernandes, D. J. (2007). Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109, 3069-3075.
36. Papp, M., Li, X., Zhuang, J., Wang, R. and Uhal, B. D. (2002). Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J. Physiol. Lung Cell Mol. Physiol. 282, L713-L718.
37. Pazdrak, K., Adachi, T. and Alam, R. (1997). Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival. J. Exp. Med. 186, 561-568.
38. Rossig, L., Hermann, C., Haendeler, J., Assmus, B., Zeiher, A. M. and Dimmeler, S. (2002). Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis. Basic Res. Cardiol. 97, 1-8.
39. Sankarshanan, M., Ma, Z., Iype, T. and Lorenz, U. (2007). Identification of a novel lipid raft-targeting motif in Src homology 2-containing phosphatase 1. J. Immunol. 179, 483-490. (Pubitemid 46986565)
40. Schwab, M. S. and Dreyer, C. (1997). Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin. Eur J. Cell Biol. 73, 287-297.
41. Sengupta, T. K., Bandyopadhyay, S., Fernandes, D. J. and Spicer, E. K. (2004). Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J. Biol. Chem. 279, 10855-10863.
42. Srivastava, M. and Pollard, H. B. (1999). Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 13, 1911-1922.
43. Strieter, R. M. (2008). What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc. Am. Thorac. Soc. 5, 305-310.
44. Sun, B. K., Deaton, A. M. and Lee, J. T. (2006). A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol. Cell 21, 617-628.
45. Sun, Y. (2009). Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction. J. Mol. Cell Cardiol. 48, 483-489.
46. Sun, Y., Zhang, J., Zhang, J. Q. and Ramires, F. J. (2000). Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension 35, 1078-1084.
47. Suzuki, Y. J., Nagase, H., Wong, C. M., Kumar, S. V., Jain, V., Park, A. M. and Day, R. M. (2007). Regulation of Bcl-xL expression in lung vascular smooth muscle. Am. J. Respir. Cell Mol. Biol. 36, 678-687. (Pubitemid 46871422)
48. Takagi, M., Absalon, M. J., McLure, K. G. and Kastan, M. B. (2005). Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123, 49-63.
49. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R. A. (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349-363.
50. Ugrinova, I., Monier, K., Ivaldi, C., Thiry, M., Storck, S., Mongelard, F. and Bouvet, P. (2007). Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol. Biol. 8, 66.
51. Uhal, B. D. (2002). Apoptosis in lung fibrosis and repair. Chest 122, 293S-298S.
52. Valencia, A. M., Oliva, J. L., Bodega, G., Chiloeches, A., Lopez-Ruiz, P., Prieto, J. C., Susini, C. and Colas, B. (1997). Identification of a protein-tyrosine phosphatase (SHP1) different from that associated with acid phosphatase in rat prostate. FEBS Lett. 406, 42-48. (Pubitemid 27156955)
53. Vogel, W., Lammers, R., Huang, J. and Ullrich, A. (1993). Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259, 1611-1614. (Pubitemid 23114640)
54. Wang, R., Ramos, C., Joshi, I., Zagariya, A., Pardo, A., Selman, M. and Uhal, B. D. (1999). Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J. Physiol. 277, L1158-L1164.
55. Wang, R., Ibarra-Sunga, O., Verlinski, L., Pick, R. and Uhal, B. D. (2000). Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L143-L151.
56. Wolf, G. (2008). Novel aspects of the renin-angiotensin-aldosterone- system. Front Biosci. 13, 4993-5005.
57. Wu, L., Iwai, M., Li, Z., Shiuchi, T., Min, L. J., Cui, T. X., Li, J. M., Okumura, M., Nahmias, C. and Horiuchi, M. (2004). Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol. Endocrinol. 18, 666-678. (Pubitemid 38328210)
58. Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210.
59. Yamada, T., Horiuchi, M. and Dzau, V. J. (1996). Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA 93, 156-160.
60. Yang, J., Liang, X., Niu, T., Meng, W., Zhao, Z. and Zhou, G. W. (1998). Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1. J. Biol. Chem. 273, 28199-28207.
61. Yi, T. L., Cleveland, J. L. and Ihle, J. N. (1992). Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol. Cell. Biol. 12, 836-846.
62. Yip, S. S., Crew, A. J., Gee, J. M., Hui, R., Blamey, R. W., Robertson, J. F., Nicholson, R. I., Sutherland, R. L. and Daly, R. J. (2000). Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int. J. Cancer 88, 363-368.
63. Yoshida, K., Kuwano, K., Hagimoto, N., Watanabe, K., Matsuba, T., Fujita, M., Inoshima, I. and Hara, N. (2002). MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. J. Pathol. 198, 388-396. (Pubitemid 35277390)
64. Zhang, H., Lawson, W. E., Polosukhin, V. V., Pozzi, A., Blackwell, T. S., Litingtung, Y. and Chiang, C. (2007). Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice. Am. J. Pathol. 171, 1113-1126.
65. Zhang, J., Tsaprailis, G. and Bowden, G. T. (2008). Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation. Cancer Res. 68, 1046-1054.
66. Zhang, L., Yu, J., Park, B. H., Kinzler, K. W. and Vogelstein, B. (2000). Role of BAX in the apoptotic response to anticancer agents. Science 290, 989-992.